Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
World Parkinson Congress Resource Report Resource Website 1+ mentions |
World Parkinson Congress (RRID:SCR_002034) | data or information resource, disease-related portal, portal, topical portal | A nonprofit organization dedicated to providing an international forum for the latest scientific discoveries, medical practices and caregiver initiatives related to Parkinson's disease. It hosts the annual World Parkinson Congress, an event which focuses on bringing physicians, scientists, allied health professionals, caregivers and people diagnosed with Parkinson's disease together, in order to create a global dialogue that will help expedite treatment practices and the discovery of a cure . | parkinson's disease, pd, international forum, disease related portal | Parkinson's disease | Free | nif-0000-11855 | SCR_002034 | World Parkinson's Disease Congress | 2026-09-19 12:49:52 | 1 | ||||||||
|
World Parkinson Disease Association Resource Report Resource Website 1+ mentions |
World Parkinson Disease Association (RRID:SCR_002035) | data or information resource, disease-related portal, portal, topical portal | THIS RESOURCE IS NO LONGER IN SERVICE, documented August 23, 2016. The World Parkinson's Disease Association is an alliance of members from all over the world who have come together to share information about Parkinson's disease. In order to further Parkinson's research and better the condition of those diagnosed with the disease, the Association: establishes computerized connections; takes part in and/or finances research activities; urges pharmaceutical companies and government institutions of the various countries to support the guidelines recommended by the associations of Parkinson's patients; and coordinates and promotes interchange of information among its members with the aim of solving problems of mutual interest. | parkinson's disease, research, therapy, pd, topical portal, disease related portal | Parkinson's disease | THIS RESOURCE IS NO LONGER IN SERVICE | nif-0000-11857 | SCR_002035 | WPDA | 2026-09-19 12:49:52 | 1 | ||||||||
|
Wellcome Trust Case Control Consortium Resource Report Resource Website 100+ mentions |
Wellcome Trust Case Control Consortium (RRID:SCR_001973) | WTCCC | data or information resource | Consortium of 50 research groups across the UK to harness the power of newly-available genotyping technologies to improve our understanding of the aetiological basis of several major causes of global disease. The consortium has gathered genotype data for up to 500,000 sites of genome sequence variation (single nucleotide polymorphisms or SNPs) in samples ascertained for the disease phenotypes. Analysis of the genome-wide association data generated has lead to the identification of many SNPs and genes showing evidence of association with disease susceptibility, some of which will be followed up in future studies. In addition, the Consortium has gained important insights into the technical, analytical, methodological and biological aspects of genome-wide association analysis. The core of the study comprised an analysis of 2,000 samples from each of seven diseases (type 1 diabetes, type 2 diabetes, coronary heart disease, hypertension, bipolar disorder, rheumatoid arthritis and Crohn's disease). For each disease, the case samples have been ascertained from sites widely distributed across Great Britain, allowing us to obtain considerable efficiencies by comparing each of these case populations to a common set of 3,000 nationally-ascertained controls also from England, Scotland and Wales. These controls come from two sources: 1,500 are representative samples from the 1958 British Birth Cohort and 1,500 are blood donors recruited by the three national UK Blood Services. One of the questions that the WTCCC study has addressed relates to the relative merits of these alternative strategies for the generation of representative population cohorts. Genotyping for this main Case Control study was conducted by Affymetrix using the (commercial) Affymetrix 500K chip. As part of this study a total of 17,000 samples were typed for 500,000 SNPs. There are two additional components to the study. First, the WTCCC award is part-funding a study of host resistance to infectious diseases in African populations. The same approach has been used to type 2,000 cases of tuberculosis (TB) and 2,000 cases of malaria, as well as 2,000 shared controls. As well as addressing diseases of major global significance, and extending WTCCC coverage into the area of infectious disease, the inclusion of samples of African origin has obvious benefits with respect to methodological aspects of genome-wide association analysis. Second, the WTCCC has, for four additional diseases (autoimmune thyroid disease, breast cancer, ankylosing spondylitis, multiple sclerosis), completed an analysis of 15,000 SNPs designed to represent a large proportion of the known non-synonymous coding SNPs across the genome. This analysis has been performed at the WTSI using a custom Infinium chip (Illumina). Data release The genotypic data of the control samples (1958 British Birth Cohort and UK Blood Service) and from seven diseases analyzed in the main study are now available to qualified researchers. Summary genotype statistics for these collections are available directly from the website. Access to the individual-level genotype data and summary genotype statistics is by application to the Consortium Data Access Committee (CDAC) and approval subject to a Data Access Agreement. WTCCC2: A further round of GWA studies were funded in April 2008. These include 15 WTCCC-collaborative studies and 12 independent studies be supported totaling approximately 120,000 samples. Many of the studies represent major international collaborative networks that have together assembled large sample collections. WTCCC2 will perform genome-wide association studies in 13 disease conditions: Ankylosing spondylitis, Barrett's oesophagus and oesophageal adenocarcinoma, glaucoma, ischaemic stroke, multiple sclerosis, pre-eclampsia, Parkinson's disease, psychosis endophenotypes, psoriasis, schizophrenia, ulcerative colitis and visceral leishmaniasis. WTCCC2 will also investigate the genetics of reading and mathematics abilities in children and the pharmacogenomics of statin response. Over 60,000 samples will be analyzed using either the Affymetrix v6.0 chip or the Illumina 660K chip. The WTCCC2 will also genotype 3,000 controls each from the 1958 British Birth cohort and the UK Blood Service control group, and the 6,000 controls will be genotyped on both the Affymetrix v6.0 and Illumina 1.2M chips. WTCCC3: The Wellcome Trust has provided support for a further round of GWA studies in January 2009. These include 5 WTCCC-collaborative studies to be carried out in WTCCC3 and 5 independent studies, across a range of diseases. Many of the studies represent major international collaborative networks that have together assembled large sample collections. WTCCC3 will perform genome-wide association studies in the following 4 disease conditions: primary biliary cirrhosis, anorexia nervosa, pre-eclampsia in UK subjects, and the interactions between donor and recipient DNA related to early and late renal transplant dysfunction. The WTCCC3 will also carry out a pilot in a study of the genetics of host control of HIV-1 infection. Over 40,000 samples will be analyzed using the Illumina 660K chip. The WTCCC3 will utilize the 6,000 control genotypes generated by the WTCCC2. | gene, genomic, genetics, microarray, genome-wide association study, snp, genome-wide association, blood, dna, genotype, variation, genome, sequence variant, copy number variation, genetic variation, phenotype, disease |
is related to: Psychiatric Genomics Consortium has parent organization: Wellcome Trust Sanger Institute; Hinxton; United Kingdom |
Bipolar disorder, Coronary artery disease, Crohn's disease, Rheumatoid arthritis, Type 1 diabetes, Type 2 diabetes, Hypertension, Control, Multiple sclerosis, Breast cancer, Ankylosing spondylitis, Autoimmune thyroid disease, Malaria, Tuberculosis, Inflammatory bowel disease, Barrett's esophagus, Esophageal adenocarcinoma, Glaucoma, Ischemic stroke, Pre-eclampsia, Parkinson's disease, Psychosis endophenotypes, Psoriasis, Schizophrenia, Ulcerative colitis, Visceral leishmaniasis, Primary biliary cirrhosis, Anorexia nervosa, Human immunodeficiency virus, Renal transplant dysfunction, Diabetes | Wellcome Trust ; Bill and Melinda Gates Foundation ; Wellcome Trust Sanger Institute; Hinxton; United Kingdom |
PMID:17554300 | Access to summary data and individual-level genotype data is available by application to the Wellcome Trust Case Control Consortium Data Access Committee. Access to data will be granted to qualified investigators for appropriate use. | nif-0000-10551 | SCR_001973 | Wellcome Trust Case-Control Consortium (WTCCC) | 2026-09-19 12:49:51 | 221 | ||||
|
Parkinson’s Disease Biomarkers Program Data Management Resource (PDBP DMR) Resource Report Resource Website 10+ mentions |
Parkinson’s Disease Biomarkers Program Data Management Resource (PDBP DMR) (RRID:SCR_002517) | PDBP | biospecimen repository, material storage repository, service resource, storage service resource | Common data management resource and web portal to promote discovery of Parkinson's Disease diagnostic and progression biomarker candidates for early detection and measurement of disease progression. PDBP will serve as multi-faceted platform for integrating existing biomarker efforts, standardizing data collection and management across these efforts, accelerating discovery of new biomarkers, and fostering and expanding collaborative opportunities for all stakeholders. | parkinson's, clinical neuroinformatics, magnetic resonance, diagnostic, progression, biomarker, clinical |
is recommended by: National Library of Medicine is listed by: NeuroImaging Tools and Resources Collaboratory (NITRC) is related to: NINDS Repository is related to: MIPAV: Medical Image Processing and Visualization has parent organization: National Institute of Neurological Disorders and Stroke |
Parkinson's disease | NINDS ; nlm |
PMID:25976927 | Restricted | nlx_155919 | http://www.nitrc.org/projects/pdbp | http://pdbp.ninds.nih.gov/index.jsp | SCR_002517 | Parkinson's Disease Biomarkers Program, PDBP: Parkinsons Disease Biomarkers Program, Parkinson’s Disease Biomarkers Program Data Management Resource, PDBP DMR | 2026-09-19 12:50:00 | 31 | ||
|
Gait Dynamics in Neuro-Degenerative Disease Data Base Resource Report Resource Website 1+ mentions |
Gait Dynamics in Neuro-Degenerative Disease Data Base (RRID:SCR_006979) | data or information resource, database | Database of records from patients with Parkinson's disease (n = 15), Huntington's disease (n = 20), or amyotrophic lateral sclerosis (n = 13). Records from 16 healthy control subjects are also included here. The raw data were obtained using force-sensitive resistors, with the output roughly proportional to the force under the foot. Stride-to-stride measures of footfall contact times were derived from these signals. | gait, neurodegenerative disease, database, parkinson, huntington, als |
is used by: NIF Data Federation has parent organization: Physiobank |
Parkinson's disease, Huntington's disease, Amyotrophic Lateral Sclerosis | Acknowledgement requested | nlx_64373 | SCR_006979 | Gait Dynamics in Neurodegenerative Disease, Gait Dynamics in Neuro-Degenerative Disease DataBase, Gait Dynamics in Neuro-Degenerative Disease Data Base | 2026-09-19 12:57:01 | 3 | |||||||
|
Gait in Parkinson's Disease Resource Report Resource Website 1+ mentions |
Gait in Parkinson's Disease (RRID:SCR_006891) | data or information resource, database | Database that contains measures of gait from 93 patients with idiopathic PD (mean age: 66.3 years; 63% men), and 73 healthy controls (mean age: 66.3 years; 55% men). The database includes the vertical ground reaction force records of subjects as they walked at their usual, self-selected pace for approximately 2 minutes on level ground. Underneath each foot were 8 sensors (Ultraflex Computer Dyno Graphy, Infotronic Inc.) that measure force (in Newtons) as a function of time. The output of each of these 16 sensors has been digitized and recorded at 100 samples per second, and the records also include two signals that reflect the sum of the 8 sensor outputs for each foot. This database also includes demographic information, measures of disease severity (i.e., using the Hoehn & Yahr staging and/or the Unified Parkinson's Disease Rating Scale) and other related measures (available in HTML or xls spreadsheet format). A subset of the database includes measures recorded as subjects performed a second task (serial 7 subtractions) while walking, which shows excerpts of swing time series from a patient with PD and a control subject, under usual walking conditions and when performing serial 7 subtractions. Under usual walking conditions, variability is larger in the patient with PD (Coefficient of Variation = 2.7%), compared to the control subject (CV = 1.3%). Variability increases during dual tasking in the subject with PD (CV = 6.5%), but not in the control subject (CV = 1.2%). | gait, speed, treadmill, stride variability |
is used by: NIF Data Federation is used by: Aging Portal has parent organization: Physiobank |
Parkinson's disease | NIH ; National Parkinson's Foundation ; Parkinson's Disease Foundation |
PMID:16053531 | Acknowledgement requested | nif-0000-00248 | SCR_006891 | 2026-09-19 12:57:00 | 1 | ||||||
|
National Disease Research Interchange Resource Report Resource Website 100+ mentions Rating or validation data |
National Disease Research Interchange (RRID:SCR_000550) | NDRI | biomaterial supply resource, material resource, tissue bank | NDRI is a Not-For-Profit (501c3) Corporation dedicated to providing the highest quality human biomaterials for research. NDRI makes it easy for researchers to get the human tissues and organs they need, prepared, preserved and shipped precisely according to their specific scientific protocols, as quickly as possible, and in the largest available quantities. NDRI provides researchers with protocol specific human neurological tissues such as brain stem, spinal cord, and basal ganglia, among others. In addition to control specimens, NDRI recovers tissues from donors with a variety of diseases, including Down syndrome, Parkinsons disease, Alzheimers disease, schizophrenia, and dementia. Through the NDRI 24/7 referral and procurement system, research consented biospecimens can be provided from low post mortem interval donors preserved at 4ºC, frozen or snap frozen, fixed, paraffin embedded, or as unstained slides. | neurological, tissue, organ, cell, neurological tissue, brainstem, spinal cord, basal ganglia, cerebral cortex, hippocampus, frozen, snap frozen, fixed, paraffin embedded, unstained slide, disease, down syndrome, parkinson's disease, alzheimer's disease, schizophrenia, dementia, control, normal, catalog |
is listed by: One Mind Biospecimen Bank Listing is listed by: Multiple Sclerosis Discovery Forum is listed by: Biospecimens/Biorepositories: Rare Disease-HUB (RD-HUB) is parent organization of: Human Tissue and Organ for Research Resource (HTORR) is parent organization of: Human Biological Data Interchange is parent organization of: NDRI Dorsal Root Ganglia Program |
Down syndrome, Parkinson's disease, Alzheimer's disease, Schizophrenia, Dementia | NIH OD011158 | Public: NDRI is a nonprofit organization that procures and distributes normal and diseased human biomaterials to biomedical researchers in academia, government, and industry. | nlx_99804 | SCR_000550 | 2026-09-19 12:56:26 | 192 | ||||||
|
Earlier versus Later Levodopa Therapy in Parkinson Disease Resource Report Resource Website |
Earlier versus Later Levodopa Therapy in Parkinson Disease (RRID:SCR_001150) | data or information resource, database | THIS RESOURCE IS NO LONGER IN SERVICE, documented August 23, 2016. This site has a dataset from the ELLDOPA study: a multicenter, placebo-controlled, randomized, dose-ranging, double-blind clinical trial of 361 early, mild Parkinson's disease (PD) subjects, not requiring symptomatic medications with a duration from time of diagnosis less than 2 years. A NINDS funded study. The multicenter, placebo-controlled, randomized, dose-ranging, double-blind clinical trial, called the Earlier versus Later Levodopa Therapy in Parkinson Disease (ELLDOPA) study was run by the Parkinson Study Group and sponsored by the National Institute of Neurological Disorders and Stroke (NINDS). The subjects (n=361) were enrolled between September 1998 and August 2001 at 33 sites in the United States and 5 sites in Canada. Despite the known benefit of levodopa in reducing the symptoms of Parkinsons disease, concern has been expressed that its use might hasten neurodegeneration. This study assessed the effect of levodopa on the rate of progression of Parkinsons disease.The primary analysis assessed the doseresponse relationship between the assigned doses and the worsening of parkinsonism, as indicated by the changes in the total score on the UPDRS between the baseline visit and week 42. Washout of study drug occurred during weeks 40-42. | ClinicalTrials.Gov: NCT00004733 | Parkinson's Disease | National Institute of Neurological Disorders and Stroke | THIS RESOURCE IS NO LONGER IN SERVICE | nif-0000-11249 | http://www.pd-doc.org/Databases/LinkedDatabases/PSGDatabases/ELLDOPAStudy/tabid/161/Default.aspx | SCR_001150 | 2026-09-19 12:56:29 | 0 | |||||||
|
Center for Imaging of Neurodegenerative Diseases Resource Report Resource Website |
Center for Imaging of Neurodegenerative Diseases (RRID:SCR_001968) | CIND | data or information resource, organization portal, portal | Biomedical technology research center that develops and validates new imaging methods for detecting brain abnormalities in neurodegenerative diseases, including Alzheimer's disease, vascular dementia, frontotemporal dementia, Parkinson's disease, as well as epilepsy, depression, and other conditions associated with nerve loss in the brain. As people around the globe live longer, the impact of neurodegenerative diseases is expected to increase further with dire social and economical consequences for societies if no effective treatments are developed soon. The development at CIND is aimed to improve magnetic resonance imaging (MRI). The ultimate goal of the scientific program is to identify imaging markers that improve accuracy in diagnosing neurodegenerative diseases at early stages, achieve more reliable prognoses of disease progression, and facilitate the discovery of effective treatment interventions. In addition to addressing the general needs for studying neurodegenerative diseases, another focus of CIND concerns brain diseases associated with military service and war combat, such as post traumatic stress disorder (PTSD), brain trauma, gulf war illness and the long-term effects of these conditions on the mental health of veterans. The symbiosis between CIND and the Veterans Administration Medical Center in San Francisco makes this program uniquely suited to serve military veterans. | Biomedical Technology Research Center, depression, mri, imaging, neuroimaging | has parent organization: University of California at San Francisco; California; USA | Neurodegenerative disease, Alzheimer's disease, Vascular dementia, Frontotemporal dementia, Parkinson's disease, Epilepsy, Depressive Disorder, Post-Traumatic Stress Disorder, Brain injury, Gulf war illness | NIBIB | THIS RESOURCE IS NO LONGER IN SERVICE | nif-0000-10539 | http://www.cind.research.va.gov/index.asp | SCR_001968 | UCSF Center for Imaging of Neurodegenerative Diseases | 2026-09-19 12:55:50 | 0 | ||||
|
Oregon Brain Bank Resource Report Resource Website |
Oregon Brain Bank (RRID:SCR_013085) | biomaterial supply resource, material resource | Brain bank that harvests, banks and disperses postmortem tissue for use in brain and medical research. It also provides neuropathologic diagnoses of organic dementia in a cohort of NIH sponsored research subjects. The bank includes tissue primarily from patients with Alzheimer's but also includes Huntington's, Parkinson's, and other disorders. | neurodegenerative research, postmortem, tissue, neurodegenerative, neurodegenerative disease, alzheimer's disease, huntington's disease, parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis, control, tissue, brain tissue, left hemisphere, right hemisphere, white matter, deep gray structure, brainstem, cerebellum, spinal cord, late adult human, flash frozen, formalin-fixed, stained, brain bank, research, medical |
is listed by: One Mind Biospecimen Bank Listing is related to: Layton Center Clinical Data Resources has parent organization: Oregon Health and Science University; Oregon; USA |
Alzheimer's disease, Huntington's disease, Parkinson's disease, Amyotrophic Lateral Sclerosis, Multiple Sclerosis, Dementia, Neurodegenerative disease, Aging | According to established protocols, For use in neurodegenerative research | nlx_35532 | SCR_013085 | Oregon Brain Bank: Human tissue repository for neurodegenerative research studies | 2026-09-19 12:58:09 | 0 | |||||||
|
Movement Disorders Biobank Resource Report Resource Website |
Movement Disorders Biobank (RRID:SCR_010659) | MDBB | biomaterial supply resource, material resource | A biobank of human biological material and genetic information. It provides samples and information to researchers in order to identify new genes and clarify pathogenic mechanisms of diseases. The biobank offers biochemical and molecular diagnoses of genetic dystonias, Parkinson's disease and NBIA disorders, as well as storage of biological samples for external institutions. | dna, fibroblast, movement disorder, neurodegeneration, brain iron accumulation disorder, dystonia, parkinson's disease, phenotype, genotype, gene, biobank |
is listed by: One Mind Biospecimen Bank Listing is related to: EuroBioBank has parent organization: EuroBioBank |
Movement disorder, Neurodegeneration with Brain Iron Accumulation disorder, Dystonia, Parkinson's disease | nlx_69108 | http://www.istituto-besta.it/Area-Ricerca.aspx?doc=Elenco-Unita-Operative&IdUO=UO-NEUROGENETICAMOLECOLARE | SCR_010659 | 2026-09-19 12:58:08 | 0 | |||||||
|
Brain Health Registry Resource Report Resource Website 10+ mentions |
Brain Health Registry (RRID:SCR_010230) | Brain Health Registry | patient registry, people resource | A website aimed at recruiting and assessing subjects for all types of neuroscience studies with the internet. The hope is to accelerate various types of observational studies and clinical trials, and also reduce costs. They are interested in having people, including healthy subjects of all ages, join the registry. Joining only takes a few minutes. The web-based project is designed to speed up cures for Alzheimer's, Parkinson's and other brain disorders. It uses online questionnaires and online neuropsychological tests (which are very much like online brain games). | questionnaire, brain test, brain, health, neuropsycholgoical test, game, clinical trial | has parent organization: University of California at San Francisco; California; USA | Alzheimer's disease, Parkinson's disease, Depressive Disorder, Traumatic brain injury, Brain disorder, Post-Traumatic Stress Disorder, Aging | Free, The community can contribute to this resource | nlx_156798 | SCR_010230 | 2026-09-19 12:58:07 | 14 | |||||||
|
Maritime Brain Tissue Bank Resource Report Resource Website |
Maritime Brain Tissue Bank (RRID:SCR_013838) | MBTB | biomaterial supply resource, material resource | A biomaterial supply resource which supplies brain tissue for researchers studying dementia and other neurodegenerative diseases. The Maritime Brain Tissue Bank archives tissues related to Alzheimer's Disease, mixed dementias, Lewy Body Disease, and Huntington's Disease, among others. | biomaterial supply resource, brain, brain tissue, dementia, neurodegenerative disease |
is listed by: Multiple Sclerosis Discovery Forum is related to: Multiple Sclerosis Discovery Forum |
Alzheimer's Disease, Mixed Dementias, Vascular Dementia, Lewy Body Disease, Progressive Supranuclear Palsy, Parkinson's Disease, Frontotemporal Dementia, Huntington's Disease, Multiple System Atrophy | Alzheimer Society of Nova Scotia ; Dalhousie University ; Capital District Health Authority |
Available to the research community, The community can contribute to this resource | SCR_013838 | 2026-09-19 12:58:10 | 0 | |||||||
|
Queen Square Brain Bank Resource Report Resource Website |
Queen Square Brain Bank (RRID:SCR_004652) | QSBB | biomaterial supply resource, material resource, tissue bank | A brain bank which holds an archive of brains donated by individuals with neurodegenerative disease and others who serve as neurologically normal controls. It specializes in parkinsonian movement disorders, including Parkinson's disease and multiple system atrophy, and holds the national collection of brains donated by individuals with progressive supranuclear palsy (PSP). Recently the collection has been developed to include donated brains from prospectively studied people with familial dementias. The QSBB also banks brains donated by people with dystonia and Gilles de la Tourette syndrome. The Brain Bank aims to provide brain tissue for neuropathological studies and for scientific research both in the UK and worldwide. The large collection of tissue is backed up by clinical documentation and all material is fully evaluated by the neuropathologists at QSBB. Brain tissue is stored as formalin-fixed, wax embedded blocks and is frozen, either at -20 degrees C or at -80 degrees C (flash-frozen). Tissue can be provided as slide-mounted sections, or as small blocks for neurochemistry, proteomics and DNA and RNA analysis. Flash-frozen material has excellent histological preservation and is suitable for in situ hybridization and immunohistochemistry. Case-control studies are matched for post-mortem delay and agonal status and are supplied blind. | neurological disorder, parkinsons disease, clinical data, human brain, brain tissue, neurodegenerative disease, neurologically normal control, progressive supranuclear palsy, parkinsonian movement disorder, multiple system atrophy, dementia, dystonia, tourettes disorder |
is listed by: One Mind Biospecimen Bank Listing has parent organization: University College London; London; United Kingdom |
Neurodegenerative disease, Progressive Supranuclear Palsy, Parkinsonian movement disorder, Parkinson's disease, Multiple system atrophy, Dementia, Dystonia, Tourettes Disorder | UCL Institute of Neurology ; Reta Lila Weston Institute of Neurological Studies UCL ; PSP Association |
Available for neuropathological studies, Tissue requests from within the UK will be covered by the QSBB ethics approval, Requesters from outside the UK must provide evidence of approval from the Human Research Ethics Committee (or equivalent) of their parent institution | nlx_143854 | SCR_004652 | Queen Square Brain Bank for Neurological Disorders, UCL Brain Bank | 2026-09-19 12:56:45 | 0 | |||||
|
Brain-Net Resource Report Resource Website 10+ mentions |
Brain-Net (RRID:SCR_005017) | biomaterial supply resource, material resource, tissue bank | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on June 28,2022. A network of several university centers in Germany that classifies neurological and psychiatric disorders neuropathologically and collects and provides brain tissue for research. The aim and task of the Brain-Net are: the collection of clinically and neuropathologically well-characterized brain tissue samples; the standardization of neuropathological diagnoses according to internationally accepted criteria; and providing a basis for future research projects using genetic, epidemiological, biometric and other issues to neurological and psychiatric disorders. | brain, tissue, autopsy, neurological disorder, mental disease, parkinson's disease, dementia, schizophrenia, suicidal tendency, depressive disorder, suicide, alzheimer's disease, amyotrophic lateral sclerosis, post mortem |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Ludwig-Maximilians-University; Munich; Germany |
Neurological disorder, Mental disease, Parkinson's disease, Dementia, Schizophrenia, Suicidal tendency, Depressive disorder, Alzheimer's disease, Amyotrophic lateral sclerosis | German Federal Ministry of Research and Education | THIS RESOURCE IS NO LONGER IN SERVICE. | nlx_144007 | SCR_005017 | BrainNet Germany, BrainNet | 2026-09-19 12:56:48 | 13 | ||||||
|
Emory Neurology Database Resource Report Resource Website |
Emory Neurology Database (RRID:SCR_005277) | data or information resource, database | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on June 9, 2025. A database which retains extensive clinical information about study subjects recruited by the Alzheimer's Disease Research Center Clinical Core, as well as other individuals with neurological diseases. In addition to clinical information, the database has basic demographics, medical history (including risk factors such as smoking), and a detailed family history from all subjects. Some entries have neuropsychological measures. Users can access a Summary Database which contains the most commonly requested variables. A data dictionary describing the variables in the Summary Database is available. | alzheimer's disease, mild cognitive impairment, dementia, lewy body disease, parkinson's disease, movement disorder, amyotrophic lateral sclerosis, stroke, sleep disorder, clinical data, family history |
is affiliated with: Emory Alzheimer's Disease Research Center is related to: Emory ADRC Tissue and Biospecimen Banking Facility |
Alzheimer's disease, Mild Cognitive Impairment, Frontotemporal dementia, Dementia, Lewy body disease, Parkinson's disease, Amyotrophic lateral sclerosis, Stroke, Sleep disorder | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_144309 | SCR_005277 | 2026-09-19 12:56:50 | 0 | ||||||||
|
Brown Brain Tissue Resource Center Resource Report Resource Website 1+ mentions |
Brown Brain Tissue Resource Center (RRID:SCR_005392) | BTRC | biomaterial supply resource, material resource, tissue bank | A tissue resource center which facilitates research into the relationship between Alzheimer's disease and other brain disorders such as strokes and mental illnesses. Most donations have been obtained from Alzheimer's patients. Normal controls are available, many of which are from subjects with close relatives with Alzheimer's. The Brown BTRC also supports a collection of brain tumor cases that were harvested from patients who underwent surgery and who were enrolled in a clinical trial for the development of new treatments for brain cancer. | alzheimer's disease, brain disorder, stroke, mental disease, memory disorder, lewy body disease, parkinson's disease, brain tumor, brain cancer, dementia, downs syndrome, brain tissue, tumor tissue, brain, clinical trial |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Brown Alpert Medical School; Rhode Island; USA |
Alzheimer's disease, Brain disorder, Stroke, Mental disease, Memory disorder, Lewy Body Disease, Parkinson's disease, Brain tumor, Brain cancer, Dementia, Downs syndrome | Available for affiliates of Brown Medical School, Available to the research community | nlx_144502 | SCR_005392 | Brown Alpert Medical School BTRC, Brown University Medical School BTRC, Brown Alpert Medical School Brain Tissue Resource Center | 2026-09-19 12:56:50 | 1 | ||||||
|
La Jolla Institute for Immunology Resource Report Resource Website |
La Jolla Institute for Immunology (RRID:SCR_014837) | LJI, | data or information resource, organization portal, portal | Non profit collaborative research organization located in La Jolla, California, UCSD Research Park. Institute researches immunology and immune system diseases to pinpoint specific genes involved, accelerate progress toward development of new treatments and vaccines to prevent and cure type 1 diabetes, cancer and infectious disease. Developer of Immune Epitope Database (IEDB). Provides core facilities with access to equipment, technologies, training and expertise to support innovative research. | Immunology, vaccine, infectious disease, immune system, Immune Epitope Database, sequencing, high throughput, bioinformatics |
is related to: Coronavirus Immunotherapy Consortium is parent organization of: Database of Immune Cell Epigenomes is parent organization of: La Jolla Institute for Immunology Next Generation Sequencing Core Facility is organization facet of: Immune Epitope Database and Analysis Resource (IEDB) |
Type 1 diabetes, Diabetes, Allergy, Alzheimer's disease, Asthma, Atherosclerosis, Atopic dermatitis, Eczema, Autoimmune disease, Cancer, COVID-19, Dengue, Ebola, Fibrosis, Food allergies, HIV, Imflammatory bowel disease, Japanese encephalitis, Lassa fever, Lung cancer, Multiple sclerosis, Nipah, Parkinson's disease, Pneumonia | SCR_014837 | LJI, la jolla, Institute for immunology, La Jolla Institute for Allergy and Immunology | 2026-09-19 12:56:04 | 0 | ||||||||
|
Kravitz Dataset 2 Resource Report Resource Website 1+ mentions |
Kravitz Dataset 2 (RRID:SCR_000296) | data or information resource, data set | Dataset of the spike and laser timestamps from Kravitz, Owen and Kretizer's 2012 paper "Optogenetic identification of striatal projection neuron subtypes during in vivo recordings." The code will analyze spike trains around laser pulses to determine if a cell is significantly activated by the laser, and therefore expresses an excitatory opsin, such as channelrhodopsin-2. It returns an excel sheet that simply identifies the activated cells. | data set, neuron, spike train, optogenetic, in vivo, laser, channelrhodopsin, matlab | has parent organization: University of California at San Francisco; California; USA | Addiction, Parkinson's disease, Tourette's syndrome | PMID:23178332 | nlx_151410 | SCR_000296 | 2026-09-19 12:58:30 | 1 | ||||||||
|
PolygenicBlog Resource Report Resource Website |
PolygenicBlog (RRID:SCR_008789) | blog, data or information resource, narrative resource | A blog concerning the relationships between genes, risk factors and immunity in Alzheimer's disease, autism, Bipolar disorder, multiple sclerosis, Parkinson's disease, schizophrenia and chronic fatigue. | gene, risk factor, immunity, alzheimer's disease, autism, bipolar disorder, multiple sclerosis, parkinson's disease, schizophrenia, chronic fatigue |
is used by: NIF Data Federation is used by: Integrated Blogs has parent organization: Polygenic Pathways |
Alzheimer's disease, Autism, Bipolar disorder, Multiple sclerosis, Parkinson's disease, Schizophrenia, Chronic fatigue | Public | nlx_144238 | SCR_008789 | Polygenic Blog | 2026-09-19 12:57:19 | 0 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the RRID Resources search. From here you can search through a compilation of resources used by RRID and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that RRID has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on RRID then you can log in from here to get additional features in RRID such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into RRID you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
